01
Hair cloning in 2026: the field has entered early clinical reality
Cell-based rejuvenation is reaching human testing, while dependable creation of new follicles remains the harder frontier.
7 min read →Research library
Understand the field before the headlines.
Evidence-based explainers, field reports and practical frameworks. Every article separates developer claims from independently established facts.
02
The three different technologies people call “hair cloning”
Rejuvenation, multiplication and de novo regeneration solve different problems—and should not be reported as equivalents.
5 min read →03
How to read a hair-regeneration breakthrough claim
A practical evidence ladder for separating an interesting experiment from a treatment people can actually receive.
6 min read →04
Dermal papilla cells: why they matter and why expansion is difficult
The instructive cells at the base of the follicle are central to several programs, but their behaviour can change in culture.
5 min read →05
From promising cells to an approved treatment
Clinical efficacy is only one part of the road: manufacturing, sterility, identity and long-term safety are equally decisive.
6 min read →06
Five signals that will determine the next five years
Human durability data, controlled trials and manufacturing—not louder forecasts—will tell us whether the field is commercialising.
5 min read →